These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 27544758)

  • 41. Characteristic patterns of dendritic remodeling in early-stage glaucoma: evidence from genetically identified retinal ganglion cell types.
    El-Danaf RN; Huberman AD
    J Neurosci; 2015 Feb; 35(6):2329-43. PubMed ID: 25673829
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship between ganglion cell layer thickness and estimated retinal ganglion cell counts in the glaucomatous macula.
    Zhang C; Tatham AJ; Weinreb RN; Zangwill LM; Yang Z; Zhang JZ; Medeiros FA
    Ophthalmology; 2014 Dec; 121(12):2371-9. PubMed ID: 25148790
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Losartan Treatment Protects Retinal Ganglion Cells and Alters Scleral Remodeling in Experimental Glaucoma.
    Quigley HA; Pitha IF; Welsbie DS; Nguyen C; Steinhart MR; Nguyen TD; Pease ME; Oglesby EN; Berlinicke CA; Mitchell KL; Kim J; Jefferys JJ; Kimball EC
    PLoS One; 2015; 10(10):e0141137. PubMed ID: 26505191
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma.
    Lambiase A; Aloe L; Centofanti M; Parisi V; Báo SN; Mantelli F; Colafrancesco V; Manni GL; Bucci MG; Bonini S; Levi-Montalcini R
    Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13469-74. PubMed ID: 19805021
    [TBL] [Abstract][Full Text] [Related]  

  • 45. JUN is important for ocular hypertension-induced retinal ganglion cell degeneration.
    Syc-Mazurek SB; Fernandes KA; Libby RT
    Cell Death Dis; 2017 Jul; 8(7):e2945. PubMed ID: 28726785
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular and cell-based approaches for neuroprotection in glaucoma.
    Lebrun-Julien F; Di Polo A
    Optom Vis Sci; 2008 Jun; 85(6):417-24. PubMed ID: 18521011
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dynein, kinesin and morphological changes in optic nerve axons in a rat model with cerebrospinal fluid pressure reduction: the Beijing Intracranial and Intraocular Pressure (iCOP) study.
    Zhang Z; Wu S; Jonas JB; Zhang J; Liu K; Lu Q; Wang N
    Acta Ophthalmol; 2016 May; 94(3):266-75. PubMed ID: 26178710
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased Susceptibility to Glaucomatous Damage in Microfibril Deficient Mice.
    Wu HJ; Kuchtey J; Kuchtey RW
    Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):28. PubMed ID: 32797197
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influences of Glaucoma on the Structure and Function of Synapses in the Visual System.
    Van Hook MJ
    Antioxid Redox Signal; 2022 Oct; 37(10-12):842-861. PubMed ID: 35044228
    [No Abstract]   [Full Text] [Related]  

  • 50. Mini-Review: Impaired Axonal Transport and Glaucoma.
    Fahy ET; Chrysostomou V; Crowston JG
    Curr Eye Res; 2016; 41(3):273-83. PubMed ID: 26125320
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insulin Signaling as a Therapeutic Target in Glaucomatous Neurodegeneration.
    Al Hussein Al Awamlh S; Wareham LK; Risner ML; Calkins DJ
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925119
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intrinsic axonal degeneration pathways are critical for glaucomatous damage.
    Howell GR; Soto I; Libby RT; John SW
    Exp Neurol; 2013 Aug; 246():54-61. PubMed ID: 22285251
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of inner retina dysfunction and progressive ganglion cell loss in a mouse model of glaucoma.
    Pérez de Lara MJ; Santano C; Guzmán-Aránguez A; Valiente-Soriano FJ; Avilés-Trigueros M; Vidal-Sanz M; de la Villa P; Pintor J
    Exp Eye Res; 2014 May; 122():40-9. PubMed ID: 24631335
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A new model of axon degeneration in the mouse optic nerve using repeat intraocular pressure challenge.
    Chrysostomou V; Bell KC; Ng SW; Suresh S; Karthik G; Millet M; Chung Y; Crowston JG
    Exp Eye Res; 2024 Jan; 238():109722. PubMed ID: 37952724
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induced autoimmunity to heat shock proteins elicits glaucomatous loss of retinal ganglion cell neurons via activated T-cell-derived fas-ligand.
    Wax MB; Tezel G; Yang J; Peng G; Patil RV; Agarwal N; Sappington RM; Calkins DJ
    J Neurosci; 2008 Nov; 28(46):12085-96. PubMed ID: 19005073
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.
    Zhong L; Bradley J; Schubert W; Ahmed E; Adamis AP; Shima DT; Robinson GS; Ng YS
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1212-8. PubMed ID: 17325165
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The neurobiology of cell death in glaucoma.
    Vrabec JP; Levin LA
    Eye (Lond); 2007 Dec; 21 Suppl 1():S11-4. PubMed ID: 18157171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement.
    Chang EE; Goldberg JL
    Ophthalmology; 2012 May; 119(5):979-86. PubMed ID: 22349567
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Time-dependent retinal ganglion cell loss, microglial activation and blood-retina-barrier tightness in an acute model of ocular hypertension.
    Trost A; Motloch K; Bruckner D; Schroedl F; Bogner B; Kaser-Eichberger A; Runge C; Strohmaier C; Klein B; Aigner L; Reitsamer HA
    Exp Eye Res; 2015 Jul; 136():59-71. PubMed ID: 26001526
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mesenchymal stromal cell-mediated neuroprotection and functional preservation of retinal ganglion cells in a rodent model of glaucoma.
    Mead B; Hill LJ; Blanch RJ; Ward K; Logan A; Berry M; Leadbeater W; Scheven BA
    Cytotherapy; 2016 Apr; 18(4):487-96. PubMed ID: 26897559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.